We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$75.3M
Cap. Flow
+$72.1M
Cap. Flow %
54.67%
Top 10 Hldgs %
4.8%
Holding
478
New
258
Increased
49
Reduced
17
Closed
154

Top Buys

Rank Stock Value
1
VSXY
Victoria's Secret
VSXY
+$912K
2
PI icon
Impinj
PI
+$749K
3
SPWR
SunPower Corporation Common Stock
SPWR
+$745K
4
SBGI icon
Sinclair Inc
SBGI
+$738K
5
FVRR icon
Fiverr
FVRR
+$728K

Top Sells

Rank Stock Value
1
MORN icon
Morningstar
MORN
+$324K
2
STNG icon
Scorpio Tankers
STNG
+$323K
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$323K
4
ARW icon
Arrow Electronics
ARW
+$323K
5
OSIS icon
OSI Systems
OSIS
+$322K

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Industrials 14.38%
3 Healthcare 14.34%
4 Consumer Discretionary 13.9%
5 Real Estate 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MELI icon
101
Mercado Libre
MELI
$92.3B
$598K 0.45%
505
+280
+124% +$352K
INTA icon
102
Intapp
INTA
$2.27B
$588K 0.45%
+14,019
New +$604K
INSP icon
103
Inspire Medical Systems
INSP
$1.47B
$586K 0.44%
+1,806
New +$516K
CMBT
104
CMB.TECH NV
CMBT
$4.46B
$581K 0.44%
38,197
+19,012
+99% +$310K
MPWR icon
105
Monolithic Power Systems
MPWR
$65.8B
$581K 0.44%
+1,076
New +$511K
ABCL icon
106
AbCellera Biologics
ABCL
$1.6B
$578K 0.44%
+89,496
New +$611K
ACT icon
107
Enact Holdings
ACT
$6.57B
$576K 0.44%
+22,940
New +$560K
PRVA icon
108
Privia Health
PRVA
$3.11B
$575K 0.44%
+22,028
New +$582K
MDGL icon
109
Madrigal Pharmaceuticals
MDGL
$12.7B
$571K 0.43%
2,470
+1,335
+118% +$362K
MBC icon
110
MasterBrand
MBC
$1.12B
$569K 0.43%
+48,966
New +$470K
MORF
111
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$566K 0.43%
+9,879
New +$516K
ALE
112
DELISTED
Allete
ALE
$557K 0.42%
+9,610
New +$594K
THC icon
113
Tenet Healthcare
THC
$21B
$556K 0.42%
+6,837
New +$487K
RDFN
114
DELISTED
Redfin
RDFN
$555K 0.42%
+44,648
New +$435K
TPG icon
115
TPG
TPG
$6.89B
$552K 0.42%
+18,859
New +$529K
OVV icon
116
Ovintiv
OVV
$16.6B
$551K 0.42%
14,479
+8,027
+124% +$290K
DV icon
117
DoubleVerify
DV
$1.68B
$549K 0.42%
+14,117
New +$456K
GMED icon
118
Globus Medical
GMED
$10.6B
$543K 0.41%
+9,113
New +$519K
OC icon
119
Owens Corning
OC
$11.6B
$538K 0.41%
+4,126
New +$452K
TCN
120
DELISTED
Tricon Residential Inc.
TCN
$537K 0.41%
+60,922
New +$498K
OM icon
121
Outset Medical
OM
$80.1M
$534K 0.4%
+1,627
New +$496K
XRX icon
122
Xerox
XRX
$357M
$532K 0.4%
+35,737
New +$523K
VISN
123
Vistance Networks Inc
VISN
$2.67B
$532K 0.4%
+94,473
New +$452K
NOW icon
124
ServiceNow
NOW
$109B
$532K 0.4%
+4,730
New +$473K
NOMD icon
125
Nomad Foods
NOMD
$1.67B
$514K 0.39%
+29,346
New +$534K
3 4
5
6 7

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q2 2023 Portfolio in Review

As of Q2 2023, Nebula Research & Development held 478 positions worth $132M, up 133% from $56.6M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $72.1M of net new capital in Q2 2023, opening 258 new positions and adding to 49 existing holdings. Its largest new stake was Victoria's Secret: 36,186 shares worth $631K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was DNOW Inc, an estimated $185K trimmed.

  • Nebula Research & Development's largest Q2 2023 buy was Victoria's Secret: 36,186 shares worth $631K.
  • Nebula Research & Development added most to The Duckhorn Portfolio, Inc. in Q2 2023, an estimated $526K increase.
  • Nebula Research & Development's biggest Q2 2023 reduction was DNOW Inc, cutting an estimated $185K.
  • Nebula Research & Development fully exited Morningstar in Q2 2023, selling an estimated $324K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $132M portfolio in Q2 2023.
  • Nebula Research & Development opened 258 new positions and closed 154 in Q2 2023.
  • Nebula Research & Development's portfolio value rose 133% quarter-over-quarter to $132M.

Based on Nebula Research & Development's 13F filing for Q2 2023, filed 14 Aug 2023.